Revolution Medicines, Inc. (RVMD)

Paramount Global Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	402.44	543.06	696.15	161.41	108.5	104.27
Short-Term Investments	1,735	1,746	1,157	483.53	468.56	336.47
Cash & Short-Term Investments	2,137	2,289	1,853	644.94	577.05	440.74
Cash Growth	34.35%	23.55%	187.31%	11.77%	30.93%	259.03%
Receivables	-	-	1.25	4.67	5.93	6.39
Prepaid Expenses	39.27	38.33	25.07	10.57	6.79	6.99
Total Current Assets	2,176	2,328	1,879	660.19	589.77	454.12
Property, Plant & Equipment	147.05	141.82	100.01	73.74	71.24	36.34
Goodwill	14.61	14.61	14.61	14.61	14.61	14.61
Other Intangible Assets	56.14	56.67	57.74	58.81	59.88	60.95
Long-Term Deferred Charges	-	-	-	-	0.5	-
Other Long-Term Assets	35.34	17.57	10.06	4.59	2	1.39
Total Assets	2,430	2,558	2,062	811.93	737.99	567.4
Accounts Payable	56.76	54.43	61.79	21.31	14.06	12.61
Accrued Expenses	114.22	96.03	70.8	28.94	27.41	18.69
Current Portion of Leases	13.09	12.87	7.37	6.77	6.21	3.67
Current Unearned Revenue	-	-	-	4.46	12.36	12.11
Other Current Liabilities	0.46	0.58	3.9	0.51	0.31	0.1
Total Current Liabilities	184.53	163.91	143.85	61.98	60.35	47.18
Long-Term Leases	119.7	122.97	80.58	57.43	60.42	28.99
Long-Term Unearned Revenue	-	-	-	-	6.57	8.48
Long-Term Deferred Tax Liabilities	2.35	2.35	3.12	7.03	7.44	7.44
Other Long-Term Liabilities	257.61	3.86	7.97	0.3	0.63	0.63
Total Liabilities	564.2	293.1	235.51	126.74	135.42	92.73
Common Stock	0.02	0.02	0.02	0.01	0.01	0.01
Additional Paid-In Capital	4,063	4,002	2,963	1,388	1,056	740.1
Retained Earnings	-2,199	-1,738	-1,138	-701.34	-452.64	-265.55
Comprehensive Income & Other	1.3	1.32	0.54	-1.78	-0.38	0.12
Total Common Equity	1,865	2,265	1,826	685.19	602.57	474.68
Shareholders' Equity	1,865	2,265	1,826	685.19	602.57	474.68
Total Liabilities & Equity	2,430	2,558	2,062	811.93	737.99	567.4
Total Debt	132.79	135.84	87.94	64.21	66.63	32.66
Net Cash (Debt)	2,004	2,153	1,765	580.74	510.42	408.08
Net Cash Growth	33.33%	22.01%	203.93%	13.78%	25.08%	232.97%
Net Cash Per Share	11.17	12.84	15.60	7.20	7.01	7.44
Filing Date Shares Outstanding	186.93	185.91	164.69	90.49	74.19	73.38
Total Common Shares Outstanding	186.9	185.9	164.67	90.41	74.14	66.6
Working Capital	1,992	2,164	1,735	598.2	529.42	406.95
Book Value Per Share	9.98	12.19	11.09	7.58	8.13	7.13
Tangible Book Value	1,795	2,194	1,754	611.77	528.08	399.12
Tangible Book Value Per Share	9.60	11.80	10.65	6.77	7.12	5.99
Machinery	36.24	31.44	28.09	21.74	14.98	11.6
Construction In Progress	0.5	0.39	0.51	-	0.13	1.98
Leasehold Improvements	21.34	14.28	11.95	11.4	7.25	3.39

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q